Local immunotherapy of cancer with interleukin 2

This publication has 21 references indexed in Scilit:

• IMMUNOTHERAPY OF SOLID TOMOR BY INTRATUMORAL INFUSION OF LYMPHOKINE‐ACTIVATED KILLER CELLS
  Japanese Journal of Cancer Research, 1988
• Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleen
  Immunology Today, 1987
• Cancer immunotherapy using local interleukin 2 administration
  Immunology Letters, 1987
• The anti-tumour efficacy of human recombinant interleukin 2
  Cancer Immunology, Immunotherapy, 1987
• Influence of the administration schedule on the therapeutic effect of interleukin-2
  International Journal of Cancer, 1987
• Tumour inhibitory effects of TCGF/IL-2/-containing preparations
  Cancer Immunology, Immunotherapy, 1985
• Growth inhibition of a MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations
  Cancer Immunology, Immunotherapy, 1983
• Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies byin vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests
  International Journal of Cancer, 1978
• Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
  Science, 1976
• Prevention of carcinogenesis by murine sarcoma virus (Harvey) following injections of immune sera during the latent period
  International Journal of Cancer, 1969